Cardiovascular slow disease management method based on intelligent decision support technology

Abstract

The invention discloses a cardiovascular slow disease management method based on intelligent decision support technology, and the method comprises the steps of S1 creating a patient's health archive; S2 assessing cardiovascular disease thrombus and hemorrhage risk; S3 tracking anticoagulant treatment curative effect and predicting medicament interruption risk; S4 long-term following a discharged or a treated cardiovascular disease patient with structured disease; S5 being supported by the doctor; and S6 being supported by the patient. The method is fused with Internet communication technology; a risk early warning model is established; data analysis and an authoritative cardiovascular disease management guide are conducted; a set of treatment decision flow with data support at real time is constructed; the patient's risk change is monitored dynamically; and the doctor's guidance and the patient's participation are combined for self management; the data analysis model is used to provide a risk assessment related to the cardiovascular disease; the cardiovascular disease treatment effect is tracked; the customized risk list of the patient's long-term self management is grabbed automatically and provided according to the patient's situation; safe medicine usage is guaranteed; and life quality is improved.

Description

technical field [0001] The invention relates to the technical field of Internet mobile medical care, in particular to a management method for cardiovascular chronic diseases based on intelligent decision support technology. Background technique [0002] Chronic diseases have become the number one killer of global residents' health, and chronic diseases such as cardiovascular and cerebrovascular diseases account for 79.4% of the total deaths of Chinese residents. 2 out of 5 deaths are due to cardiovascular disease. There are currently 290 million cardiovascular disease patients nationwide, including 270 million hypertension, 7 million strokes, 2.5 million myocardial infarctions, and 4.5 million heart failures. At present, the cost of treating cardiovascular and cerebrovascular diseases in China has reached 300 billion yuan a year. It is predicted that in the next 20 years, the incidence of cardiovascular diseases in Chinese adults will increase by more than 50%, which will i...

AI Technical Summary

Problems solved by technology

The average anticoagulant rate of Chinese atrial fibrillation population is less than 20%, failing to effectively prevent atrial fibrillation and its complications such as stroke

However, how to make good use of drugs and help patients obtain maximum anticoagulant benefits is an urgent problem for clinicians and patients to solve. These practical problems of safe drug use include anticoagulant strategy selection, patient drug compliance, and long-term management of drug bleeding risks Wait

The above-mentioned deficiencies are not only reflected in the period of patient consultation or hospitalization, but especially in the long-term management of patients after discharge. It is often difficult for patients to obtain continuous and effective treatment.

Images